Charles River Laboratories International CRL
NYSE CRL
$296.78 +1.68 (+0.57%)
As of: Aug 27, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Revenue Growth (3y) (2012 - 2026)

Charles River Laboratories International (CRL) Revenue Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 3.92%
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 1.95%
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 42.27%
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 2.24%
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn 5.42%
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 8.84%
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -0.48%
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 1.51%
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 7.14%
10 Charles River Laboratories International 14.28 Bn 14.09 Bn 452.07 Mn -1.79%

Historic Data

Download Data
DateValue
Jun 27, 2026 -1.79%
Dec 27, 2025 -3.31%
Sep 27, 2025 0.53%
Jun 28, 2025 1.98%
Mar 29, 2025 2.50%
Dec 28, 2024 3.47%
Sep 28, 2024 4.07%
Jun 29, 2024 3.91%
Mar 30, 2024 7.05%
Dec 30, 2023 8.61%
Sep 30, 2023 11.37%
Jul 1, 2023 15.80%
Apr 1, 2023 13.34%
Dec 31, 2022 16.75%
Sep 24, 2022 13.98%
Jun 25, 2022 13.96%
Mar 26, 2022 14.77%
Dec 25, 2021 14.59%
Sep 25, 2021 15.25%
Jun 26, 2021 16.04%